Neumann Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $469K | Hold |
2,226
| – | – | 0.12% | 84 |
|
|
2026
Q2 | $423K | Sell |
2,226
-12
| -0.5% | -$2.06K | 0.28% | 46 |
|
|
2026
Q1 | $378K | Hold |
2,238
| – | – | 0.11% | 87 |
|
|
2025
Q4 | $378K | Hold |
2,238
| – | – | 0.11% | 88 |
|
|
2025
Q3 | $323K | Hold |
2,238
| – | – | 0.09% | 92 |
|
|
2025
Q2 | $283K | Hold |
2,238
| – | – | 0.09% | 92 |
|
|
2025
Q1 | $286K | Hold |
2,238
| – | – | 0.1% | 93 |
|
|
2024
Q4 | $296K | Hold |
2,238
| – | – | 0.1% | 92 |
|
|
2024
Q3 | $326K | Hold |
2,238
| – | – | 0.11% | 91 |
|
|
2024
Q2 | $307K | Hold |
2,238
| – | – | 0.11% | 88 |
|
|
2024
Q1 | $307K | Hold |
2,238
| – | – | 0.11% | 85 |
|
|
2023
Q4 | $304K | Hold |
2,238
| – | – | 0.12% | 86 |
|
|
2023
Q3 | $274K | Buy |
2,238
+180
| +9% | +$22.9K | 0.12% | 83 |
|
|
2023
Q2 | $261K | Hold |
2,058
| – | – | 0.11% | 86 |
|
|
2023
Q1 | $266K | Hold |
2,058
| – | – | 0.12% | 86 |
|
|
2022
Q4 | $270K | Hold |
2,058
| – | – | 0.13% | 80 |
|
|
2022
Q3 | $241K | Hold |
2,058
| – | – | 0.12% | 82 |
|
|
2022
Q2 | $242K | Hold |
2,058
| – | – | 0.12% | 76 |
|
|
2022
Q1 | $268K | Sell |
2,058
-800
| -28% | -$104K | 0.11% | 82 |
|
|
2021
Q4 | $436K | Sell |
2,858
-800
| -22% | -$124K | 0.18% | 67 |
|
|
2021
Q3 | $591K | Hold |
3,658
| – | – | 0.27% | 62 |
|
|
2021
Q2 | $599K | Hold |
3,658
| – | – | 0.27% | 60 |
|
|
2021
Q1 | $551K | Hold |
3,658
| – | – | 0.26% | 60 |
|
|
2020
Q4 | $554K | Hold |
3,658
| – | – | 0.28% | 58 |
|
|
2020
Q3 | $495K | Hold |
3,658
| – | – | 0.28% | 58 |
|
|
2020
Q2 | $500K | Hold |
3,658
| – | – | 0.31% | 59 |
|
|
2020
Q1 | $394K | Buy |
3,658
+956
| +35% | +$110K | 0.29% | 59 |
|
|
2019
Q4 | $326K | Sell |
2,702
-956
| -26% | -$107K | 0.19% | 65 |
|
|
2019
Q3 | $364K | Hold |
3,658
| – | – | 0.23% | 64 |
|
|
2019
Q2 | $399K | Sell |
3,658
-100
| -3% | -$10.6K | 0.25% | 63 |
|
|
2019
Q1 | $420K | Hold |
3,758
| – | – | 0.27% | 63 |
|
|
2018
Q4 | $362K | Sell |
3,758
-150
| -4% | -$15.9K | 0.27% | 62 |
|
|
2018
Q3 | $477K | Hold |
3,908
| – | – | 0.28% | 60 |
|
|
2018
Q2 | $429K | Hold |
3,908
| – | – | 0.27% | 60 |
|
|
2018
Q1 | $417K | Sell |
3,908
-570
| -13% | -$63.2K | 0.27% | 60 |
|
|
2017
Q4 | $478K | Sell |
4,478
-1
| -0% | -$107 | 0.29% | 65 |
|
|
2017
Q3 | $498K | Hold |
4,479
| – | – | 0.31% | 65 |
|
|
2017
Q2 | $463K | Hold |
4,479
| – | – | 0.3% | 65 |
|
|
2017
Q1 | $438K | Sell |
4,479
-3,630
| -45% | -$348K | 0.28% | 66 |
|
|
2016
Q4 | $717K | Hold |
8,109
| – | – | 0.46% | 54 |
|
|
2016
Q3 | $782K | Hold |
8,109
| – | – | 0.52% | 50 |
|
|
2016
Q2 | $696K | Hold |
8,109
| – | – | 0.46% | 51 |
|
|
2016
Q1 | $705K | Hold |
8,109
| – | – | 0.46% | 53 |
|
|
2015
Q4 | $915K | Hold |
8,109
| – | – | 0.64% | 48 |
|
|
2015
Q3 | $820K | Hold |
8,109
| – | – | 0.58% | 51 |
|
|
2015
Q2 | $997K | Hold |
8,109
| – | – | 0.64% | 50 |
|
|
2015
Q1 | $928K | Hold |
8,109
| – | – | 0.59% | 53 |
|
|
2014
Q4 | $820K | Buy |
+8,109
| New | +$788K | 0.53% | 54 |
|
Other funds holding IBB
Neumann Capital Management's IBB Position: Q3 2026 in Review
Neumann Capital Management held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 2,226 shares worth $469K. The position accounts for 0.12% of the portfolio, ranked #84.
Neumann Capital Management first reported a position in IBB in Q4 2014 and has held it in 48 quarters since. The position peaked at $997K in Q2 2015. 671 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Neumann Capital Management held 2,226 shares of iShares Biotechnology ETF worth $469K as of Q3 2026.
- Neumann Capital Management left its iShares Biotechnology ETF share count unchanged in Q3 2026.
- iShares Biotechnology ETF made up 0.12% of Neumann Capital Management's portfolio in Q3 2026, its #84 holding.
- Neumann Capital Management first reported a position in iShares Biotechnology ETF in Q4 2014 and has held it in 48 quarters since.
- Neumann Capital Management's iShares Biotechnology ETF position peaked at $997K in Q2 2015.
- 671 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Neumann Capital Management's 13F filing for Q3 2026, filed 15 Oct 2026.